array:24 [
  "pii" => "S2174204916301076"
  "issn" => "21742049"
  "doi" => "10.1016/j.repce.2015.11.032"
  "estado" => "S300"
  "fechaPublicacion" => "2016-07-01"
  "aid" => "840"
  "copyright" => "Sociedade Portuguesa de Cardiologia"
  "copyrightAnyo" => "2016"
  "documento" => "simple-article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "crp"
  "cita" => "Rev Port Cardiol. 2016;35:447.e1-3"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 2606
    "formatos" => array:3 [
      "EPUB" => 190
      "HTML" => 2018
      "PDF" => 398
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S2174204916301088"
    "issn" => "21742049"
    "doi" => "10.1016/j.repce.2015.08.016"
    "estado" => "S300"
    "fechaPublicacion" => "2016-07-01"
    "aid" => "842"
    "copyright" => "Sociedade Portuguesa de Cardiologia"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "sco"
    "cita" => "Rev Port Cardiol. 2016;35:449-50"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 1959
      "formatos" => array:3 [
        "EPUB" => 151
        "HTML" => 1456
        "PDF" => 352
      ]
    ]
    "en" => array:11 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Image in Cardiology</span>"
      "titulo" => "Right ventricular hematoma"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "449"
          "paginaFinal" => "450"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "pt" => array:1 [
          "titulo" => "Hematoma do ventr&#237;culo direito"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0005"
          "etiqueta" => "Figure 1"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr1.jpeg"
              "Alto" => 1776
              "Ancho" => 2918
              "Tamanyo" => 479355
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">&#40;A&#41; Two-dimensional transthoracic echocardiography&#44; modified short-axis view at the sub-tricuspid level&#44; depicting a well-defined right ventricular mass &#40;&#42;&#41; and part of the right coronary artery course along the atrioventricular groove &#40;arrow&#41;&#59; &#40;B&#41; three-dimensional &#40;3D&#41; transthoracic echocardiography&#44; live 3D bird&#39;s eye view&#44; modified 4-chamber view&#44; showing a homogeneous and delimited ovoid mass &#40;&#42;&#41; on a sub-tricuspid position&#59; &#40;C and D&#41; mid-ventricular short-axis T1 and fat sat T2-weighted turbo spin-echo sequences&#44; respectively&#44; showing a hypointense homogeneous right ventricular mass &#40;&#42;&#41; with no fat tissue&#59; &#40;E and F&#41; mid-ventricular short-axis T1 post-contrast and phase-sensitive inversion recovery sequences&#44; respectively&#44; illustrating a small hyperintense core &#40;arrowhead&#41; inside the mass &#40;&#42;&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Rui Pl&#225;cido, Jo&#227;o Abecasis, Susana Gon&#231;alves, Fausto J&#46; Pinto, Ana G&#46; Almeida"
          "autores" => array:5 [
            0 => array:2 [
              "nombre" => "Rui"
              "apellidos" => "Pl&#225;cido"
            ]
            1 => array:2 [
              "nombre" => "Jo&#227;o"
              "apellidos" => "Abecasis"
            ]
            2 => array:2 [
              "nombre" => "Susana"
              "apellidos" => "Gon&#231;alves"
            ]
            3 => array:2 [
              "nombre" => "Fausto J&#46;"
              "apellidos" => "Pinto"
            ]
            4 => array:2 [
              "nombre" => "Ana"
              "apellidos" => "G&#46; Almeida"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204916301088?idApp=UINPBA00004E"
    "url" => "/21742049/0000003500000078/v2_201704060238/S2174204916301088/v2_201704060238/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2174204916301064"
    "issn" => "21742049"
    "doi" => "10.1016/j.repce.2015.10.027"
    "estado" => "S300"
    "fechaPublicacion" => "2016-07-01"
    "aid" => "843"
    "copyright" => "Sociedade Portuguesa de Cardiologia"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "crp"
    "cita" => "Rev Port Cardiol. 2016;35:445&#46;e1-4"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 2519
      "formatos" => array:3 [
        "EPUB" => 178
        "HTML" => 1962
        "PDF" => 379
      ]
    ]
    "en" => array:13 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>"
      "titulo" => "Combined venoarterial extracorporeal membrane oxygenation and transcatheter aortic valve implantation for the treatment of acute aortic prosthesis dysfunction in a high-risk patient"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "pt"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "445&#46;e1"
          "paginaFinal" => "445&#46;e4"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "pt" => array:1 [
          "titulo" => "Uso combinado de oxigena&#231;&#227;o da membrana extracorporal e implanta&#231;&#227;o percut&#226;nea da v&#225;lvula a&#243;rtica para o tratamento de disfun&#231;&#227;o prost&#233;tica a&#243;rtica aguda num doente de alto risco"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "pt" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0020"
          "etiqueta" => "Figure 4"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr4.jpeg"
              "Alto" => 1025
              "Ancho" => 1589
              "Tamanyo" => 125489
            ]
          ]
          "descripcion" => array:1 [
            "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Transesophageal echocardiography&#44; 4-chamber mid-esophageal view&#44; showing prosthesis degeneration and cusp tears &#40;red arrow&#41;&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Amedeo Pergolini, Giordano Zampi, Maria Denitza Tinti, Vincenzo Polizzi, Paolo Giuseppe Pino, Daniele Pontillo, Francesco Musumeci, Giampaolo Luzi"
          "autores" => array:8 [
            0 => array:2 [
              "nombre" => "Amedeo"
              "apellidos" => "Pergolini"
            ]
            1 => array:2 [
              "nombre" => "Giordano"
              "apellidos" => "Zampi"
            ]
            2 => array:2 [
              "nombre" => "Maria Denitza"
              "apellidos" => "Tinti"
            ]
            3 => array:2 [
              "nombre" => "Vincenzo"
              "apellidos" => "Polizzi"
            ]
            4 => array:2 [
              "nombre" => "Paolo Giuseppe"
              "apellidos" => "Pino"
            ]
            5 => array:2 [
              "nombre" => "Daniele"
              "apellidos" => "Pontillo"
            ]
            6 => array:2 [
              "nombre" => "Francesco"
              "apellidos" => "Musumeci"
            ]
            7 => array:2 [
              "nombre" => "Giampaolo"
              "apellidos" => "Luzi"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204916301064?idApp=UINPBA00004E"
    "url" => "/21742049/0000003500000078/v2_201704060238/S2174204916301064/v2_201704060238/en/main.assets"
  ]
  "en" => array:19 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Case report</span>"
    "titulo" => "Rivaroxaban for the treatment of saphenous vein graft thrombosis"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "447&#46;e1"
        "paginaFinal" => "447&#46;e3"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Konstantinos Marmagkiolis, Mehmet Cilingiroglu"
        "autores" => array:2 [
          0 => array:3 [
            "nombre" => "Konstantinos"
            "apellidos" => "Marmagkiolis"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:4 [
            "nombre" => "Mehmet"
            "apellidos" => "Cilingiroglu"
            "email" => array:1 [
              0 => "cilingiroglumehmet&#64;gmail&#46;com"
            ]
            "referencia" => array:3 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
              2 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Citizens Memorial Hospital&#44; Heart and Vascular Institute&#44; Bolivar&#44; MO&#44; USA"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Arkansas Heart Hospital&#47;University of Arkansas for Medical Sciences&#44; Little Rock&#44; AR&#44; USA"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Koc University&#44; School of Medicine&#44; Istanbul&#44; Turkey"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Corresponding author&#46;"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "pt" => array:1 [
        "titulo" => "O rivaroxabano no tratamento da trombose do enxerto de veia safena"
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0015"
        "etiqueta" => "Figure 3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr3.jpeg"
            "Alto" => 1584
            "Ancho" => 1585
            "Tamanyo" => 163035
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Saphenous vein graft to second obtuse marginal four weeks after rivaroxaban&#44; in left anterior oblique view&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Case report</span><p id="par0005" class="elsevierStylePara elsevierViewall">A 67-year-old woman with a history of coronary artery bypass grafting &#40;CABG&#41; six months previously underwent coronary angiography for stable class III angina&#46; Extensive thrombus burden was visualized in the mid-distal segment of the saphenous vein graft &#40;SVG&#41; to the second obtuse marginal branch with decreased Thrombolysis In Myocardial Infarction &#40;TIMI&#41; 2 flow &#40;<a class="elsevierStyleCrossRefs" href="#fig0005">Figures 1 and 2</a>&#41; and without evidence of obstructive atherosclerosis&#46; The patient was placed on oral anticoagulation with rivaroxaban &#40;Janssen Pharmaceuticals&#44; Titusville&#44; NJ&#44; USA&#41; 20 mg once daily&#46; Follow-up catheterization after four weeks revealed angiographic resolution of the thrombus with significantly improved TIMI 3 flow &#40;<a class="elsevierStyleCrossRefs" href="#fig0015">Figures 3 and 4</a>&#41;&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><elsevierMultimedia ident="fig0010"></elsevierMultimedia><elsevierMultimedia ident="fig0015"></elsevierMultimedia><elsevierMultimedia ident="fig0020"></elsevierMultimedia><p id="par0010" class="elsevierStylePara elsevierViewall">Rivaroxaban is a new oral anticoagulant&#44; a direct factor Xa inhibitor which is currently FDA approved for the prevention and treatment of venous thromboembolism&#44; and for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation&#46;<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">1</span></a> ATLAS ACS 2-TIMI 51 demonstrated reduced risk of the composite end point of death from cardiovascular causes&#44; myocardial infarction&#44; or stroke in patients with a recent acute coronary syndrome placed on rivaroxaban at the expense of increased risk of non-fatal major bleeding and intracranial hemorrhage&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">2</span></a> Thrombosis&#44; intimal hyperplasia and atherosclerosis are the common mechanisms of SVG disease and occlusion&#59; however&#44; the Post CABG trial failed to demonstrate higher SVG primary patency rates with low-dose anticoagulation with warfarin as a primary prevention strategy&#46;<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">3</span></a> This case highlights the potential benefit of the new-generation oral anticoagulants in the secondary prevention and treatment of saphenous vein thrombosis-related disease&#46; A similar approach was reported by Fiorina et al&#46; in a small case series of 14 patients with non-ST-elevation myocardial infarction and occluded SVGs&#44; in which after angioplasty with an undersized balloon to achieve TIMI flow 1-2&#44; patients were placed on anticoagulation with warfarin for 11&#177;7 days&#46; A follow-up angiogram revealed that all the SVGs were patent&#44; 14&#37; of them with no residual lesions&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">4</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Ethical disclosures</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Protection of human and animal subjects</span><p id="par0015" class="elsevierStylePara elsevierViewall">The authors declare that no experiments were performed on humans or animals for this study&#46;</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Confidentiality of data</span><p id="par0020" class="elsevierStylePara elsevierViewall">The authors declare that they have followed the protocols of their work center on the publication of patient data&#46;</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Right to privacy and informed consent</span><p id="par0025" class="elsevierStylePara elsevierViewall">The authors declare that no patient data appear in this article&#46;</p></span></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conflicts of interest</span><p id="par0030" class="elsevierStylePara elsevierViewall">The authors have no conflicts of interest to declare&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:8 [
        0 => array:3 [
          "identificador" => "xres825323"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec821812"
          "titulo" => "Keywords"
        ]
        2 => array:3 [
          "identificador" => "xres825324"
          "titulo" => "Resumo"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0010"
            ]
          ]
        ]
        3 => array:2 [
          "identificador" => "xpalclavsec821811"
          "titulo" => "Palavras-chave"
        ]
        4 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Case report"
        ]
        5 => array:3 [
          "identificador" => "sec0010"
          "titulo" => "Ethical disclosures"
          "secciones" => array:3 [
            0 => array:2 [
              "identificador" => "sec0015"
              "titulo" => "Protection of human and animal subjects"
            ]
            1 => array:2 [
              "identificador" => "sec0020"
              "titulo" => "Confidentiality of data"
            ]
            2 => array:2 [
              "identificador" => "sec0025"
              "titulo" => "Right to privacy and informed consent"
            ]
          ]
        ]
        6 => array:2 [
          "identificador" => "sec0030"
          "titulo" => "Conflicts of interest"
        ]
        7 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2015-07-15"
    "fechaAceptado" => "2015-11-21"
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec821812"
          "palabras" => array:3 [
            0 => "Saphenous vein graft disease"
            1 => "Thrombus"
            2 => "Anticoagulant"
          ]
        ]
      ]
      "pt" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palavras-chave"
          "identificador" => "xpalclavsec821811"
          "palabras" => array:3 [
            0 => "Doen&#231;a do enxerto da veia safena"
            1 => "Trombose"
            2 => "Anticoagulantes"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Thrombus formafigtion plays a significant role in disease of saphenous vein bypass grafts&#46; Use of oral anticoagulants has not been tested in treatment of thrombotic occlusion of saphenous vein graft &#40;SVG&#41; disease&#46; Here we describe the use of the novel oral anticoagulant rivaroxaban in the treatment of occlusive SVG disease with intraluminal thrombus&#44; leading to successful recanalization&#46;</p></span>"
      ]
      "pt" => array:2 [
        "titulo" => "Resumo"
        "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A forma&#231;&#227;o de trombos tem um papel significativo na doen&#231;a do <span class="elsevierStyleItalic">bypass</span> do enxerto da veia safena &#40;EVS&#41;&#46; A utiliza&#231;&#227;o de anticoagulantes orais n&#227;o foi testada no tratamento da oclus&#227;o tromb&#243;tica na doen&#231;a do EVS&#46; Apresentamos o uso de um novo anticoagulante oral&#44; o rivaroxabano&#44; no tratamento da doen&#231;a oclusiva do EVS com trombo intraluminal e recanaliza&#231;&#227;o bem-sucedida&#46;</p></span>"
      ]
    ]
    "multimedia" => array:4 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 1583
            "Ancho" => 1585
            "Tamanyo" => 168792
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Saphenous vein graft to second obtuse marginal at baseline&#44; in left anterior oblique view&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "fig0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 1584
            "Ancho" => 1585
            "Tamanyo" => 165727
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Saphenous vein graft to second obtuse marginal at baseline&#44; in right anterior oblique view&#46;</p>"
        ]
      ]
      2 => array:7 [
        "identificador" => "fig0015"
        "etiqueta" => "Figure 3"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr3.jpeg"
            "Alto" => 1584
            "Ancho" => 1585
            "Tamanyo" => 163035
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Saphenous vein graft to second obtuse marginal four weeks after rivaroxaban&#44; in left anterior oblique view&#46;</p>"
        ]
      ]
      3 => array:7 [
        "identificador" => "fig0020"
        "etiqueta" => "Figure 4"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr4.jpeg"
            "Alto" => 1584
            "Ancho" => 1585
            "Tamanyo" => 169780
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Saphenous vein graft to second obtuse marginal four weeks after rivaroxaban&#44; in right anterior oblique view&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:4 [
            0 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:3 [
                  "comentario" => "&#91;Epub ahead of print&#93;"
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Novel oral anticoagulants in acute coronary syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "C&#46; Costopoulos"
                            1 => "M&#46; Niespialowska-Steuden"
                            2 => "N&#46; Kukreja"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "Int J Card"
                        "fecha" => "2012"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Rivaroxaban in patients with recent acute coronary syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "J&#46;L&#46; Mega"
                            1 => "E&#46; Braunwald"
                            2 => "S&#46;D&#46; Wiviott"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMoa1112277"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2012"
                        "volumen" => "366"
                        "paginaInicial" => "9"
                        "paginaFinal" => "19"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22077192"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts"
                      "autores" => array:1 [
                        0 => array:2 [
                          "colaboracion" => "The Post CABG Investigators"
                          "etal" => false
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJM199701163360301"
                      "Revista" => array:6 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "1997"
                        "volumen" => "336"
                        "paginaInicial" => "153"
                        "paginaFinal" => "162"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8992351"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Early experience with a new approach for percutaneous intervention of totally occluded saphenous vein graft&#58; is the flow the best thrombolytic&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => true
                          "autores" => array:3 [
                            0 => "C&#46; Fiorina"
                            1 => "E&#46; Meliga"
                            2 => "G&#46; Chizzola"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.4244/EIJ30V6I4A78"
                      "Revista" => array:6 [
                        "tituloSerie" => "EuroIntervention"
                        "fecha" => "2010"
                        "volumen" => "6"
                        "paginaInicial" => "461"
                        "paginaFinal" => "466"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20884433"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/21742049/0000003500000078/v2_201704060238/S2174204916301076/v2_201704060238/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "9919"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Case Reports"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/21742049/0000003500000078/v2_201704060238/S2174204916301076/v2_201704060238/en/main.pdf?idApp=UINPBA00004E&text.app=https://revportcardiol.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2174204916301076?idApp=UINPBA00004E"
]
Share
Journal Information
Vol. 35. Issue 7 - 8.
Pages 447.e1-447.e3 (July - August 2016)
Share
Share
Download PDF
More article options
Visits
5254
Vol. 35. Issue 7 - 8.
Pages 447.e1-447.e3 (July - August 2016)
Case report
Open Access
Rivaroxaban for the treatment of saphenous vein graft thrombosis
O rivaroxabano no tratamento da trombose do enxerto de veia safena
Visits
5254
Konstantinos Marmagkiolisa, Mehmet Cilingiroglub,c,
Corresponding author
cilingiroglumehmet@gmail.com

Corresponding author.
a Citizens Memorial Hospital, Heart and Vascular Institute, Bolivar, MO, USA
b Arkansas Heart Hospital/University of Arkansas for Medical Sciences, Little Rock, AR, USA
c Koc University, School of Medicine, Istanbul, Turkey
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (4)
Show moreShow less
Abstract

Thrombus formafigtion plays a significant role in disease of saphenous vein bypass grafts. Use of oral anticoagulants has not been tested in treatment of thrombotic occlusion of saphenous vein graft (SVG) disease. Here we describe the use of the novel oral anticoagulant rivaroxaban in the treatment of occlusive SVG disease with intraluminal thrombus, leading to successful recanalization.

Keywords:
Saphenous vein graft disease
Thrombus
Anticoagulant
Resumo

A formação de trombos tem um papel significativo na doença do bypass do enxerto da veia safena (EVS). A utilização de anticoagulantes orais não foi testada no tratamento da oclusão trombótica na doença do EVS. Apresentamos o uso de um novo anticoagulante oral, o rivaroxabano, no tratamento da doença oclusiva do EVS com trombo intraluminal e recanalização bem-sucedida.

Palavras-chave:
Doença do enxerto da veia safena
Trombose
Anticoagulantes
Full Text
Case report

A 67-year-old woman with a history of coronary artery bypass grafting (CABG) six months previously underwent coronary angiography for stable class III angina. Extensive thrombus burden was visualized in the mid-distal segment of the saphenous vein graft (SVG) to the second obtuse marginal branch with decreased Thrombolysis In Myocardial Infarction (TIMI) 2 flow (Figures 1 and 2) and without evidence of obstructive atherosclerosis. The patient was placed on oral anticoagulation with rivaroxaban (Janssen Pharmaceuticals, Titusville, NJ, USA) 20 mg once daily. Follow-up catheterization after four weeks revealed angiographic resolution of the thrombus with significantly improved TIMI 3 flow (Figures 3 and 4).

Figure 1.

Saphenous vein graft to second obtuse marginal at baseline, in left anterior oblique view.

(0.16MB).
Figure 2.

Saphenous vein graft to second obtuse marginal at baseline, in right anterior oblique view.

(0.16MB).
Figure 3.

Saphenous vein graft to second obtuse marginal four weeks after rivaroxaban, in left anterior oblique view.

(0.16MB).
Figure 4.

Saphenous vein graft to second obtuse marginal four weeks after rivaroxaban, in right anterior oblique view.

(0.16MB).

Rivaroxaban is a new oral anticoagulant, a direct factor Xa inhibitor which is currently FDA approved for the prevention and treatment of venous thromboembolism, and for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation.1 ATLAS ACS 2-TIMI 51 demonstrated reduced risk of the composite end point of death from cardiovascular causes, myocardial infarction, or stroke in patients with a recent acute coronary syndrome placed on rivaroxaban at the expense of increased risk of non-fatal major bleeding and intracranial hemorrhage.2 Thrombosis, intimal hyperplasia and atherosclerosis are the common mechanisms of SVG disease and occlusion; however, the Post CABG trial failed to demonstrate higher SVG primary patency rates with low-dose anticoagulation with warfarin as a primary prevention strategy.3 This case highlights the potential benefit of the new-generation oral anticoagulants in the secondary prevention and treatment of saphenous vein thrombosis-related disease. A similar approach was reported by Fiorina et al. in a small case series of 14 patients with non-ST-elevation myocardial infarction and occluded SVGs, in which after angioplasty with an undersized balloon to achieve TIMI flow 1-2, patients were placed on anticoagulation with warfarin for 11±7 days. A follow-up angiogram revealed that all the SVGs were patent, 14% of them with no residual lesions.4

Ethical disclosuresProtection of human and animal subjects

The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data

The authors declare that they have followed the protocols of their work center on the publication of patient data.

Right to privacy and informed consent

The authors declare that no patient data appear in this article.

Conflicts of interest

The authors have no conflicts of interest to declare.

References
[1]
C. Costopoulos, M. Niespialowska-Steuden, N. Kukreja, et al.
Novel oral anticoagulants in acute coronary syndrome.
Int J Card, (2012),
[Epub ahead of print]
[2]
J.L. Mega, E. Braunwald, S.D. Wiviott, et al.
Rivaroxaban in patients with recent acute coronary syndrome.
N Engl J Med, 366 (2012), pp. 9-19
[3]
The Post CABG Investigators.
The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.
N Engl J Med, 336 (1997), pp. 153-162
[4]
C. Fiorina, E. Meliga, G. Chizzola, et al.
Early experience with a new approach for percutaneous intervention of totally occluded saphenous vein graft: is the flow the best thrombolytic?.
EuroIntervention, 6 (2010), pp. 461-466
Copyright © 2016. Sociedade Portuguesa de Cardiologia
Download PDF
Idiomas
Revista Portuguesa de Cardiologia (English edition)
Article options
Tools
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

By checking that you are a health professional, you are stating that you are aware and accept that the Portuguese Journal of Cardiology (RPC) is the Data Controller that processes the personal information of users of its website, with its registered office at Campo Grande, n.º 28, 13.º, 1700-093 Lisbon, telephone 217 970 685 and 217 817 630, fax 217 931 095, and email revista@spc.pt. I declare for all purposes that the information provided herein is accurate and correct.